- $1.21bn
- $2.00bn
- $6.32bn
Annual balance sheet for Ardent Health, fiscal year end - December 31st, millions except per share.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | |
| Standards: | — | USG | USG | USG | USG |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | 456 | 438 | 557 | 710 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 641 | 810 | 786 | 707 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | — | 1,409 | 1,618 | 1,833 | 2,059 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 1,990 | 2,012 | 2,039 | 2,144 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | — | 4,479 | 4,732 | 4,956 | 5,290 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | — | 809 | 994 | 945 | 1,047 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | — | 3,840 | 4,061 | 3,825 | 4,002 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | — | 639 | 671 | 1,131 | 1,288 |
| Total Liabilities & Shareholders' Equity | — | 4,479 | 4,732 | 4,956 | 5,290 |
| Total Common Shares Outstanding |